Now, the combination of bupropion and naltrexone is being studied for possible weight-loss effects through its synergistic action on appetite signaling and the mesolimbic reward system.

Further studies should include broader populations and head-to-head comparisons of bupropion/naltrexone with other active weight-loss agents. An editorialist warns that known psychiatric and ...

Clinical Research: Effect of combined GLP-1 analogue and bupropion/naltrexone on weight loss: a retrospective cohort study. Image Credit: MillaF / Shutterstock Obesity is associated with several ...

However, the association with bupropion and naltrexone became statistically insignificant when adjusted for weight loss. Researchers hypothesized that certain pharmacological properties of obesity ...

The campaign inspires individuals to seek help in taking control of their weight-loss efforts with CONTRAVE, an established ...

The weight loss medications on the market today are ... followed by 5.4 percent with liraglutide (Saxenda), 4 percent with naltrexone-bupropion (Contrave), and 2.9 percent with orlistat (Xenical).

Currax Pharmaceuticals is taking a page out of Lesley Gore’s playbook to remind patients that obesity doesn’t own them. The drugmaker launched a campaign supporting its weight loss medication ...

While Contrave is a pill that is taken twice daily, the most common forms of GLP-1s used for weight loss are subcutaneous injections given once a week. “Naltrexone has a half-life of 5 hours ...